Furthermore, we demonstrated that neutralizing antibodies to IL-33 and/or IL-1R1, or an inhibitor of IRAK4 (involved in MyD88 signaling) were effective for the treatment of endometriosis in this model. Here, IL1R1 is linked to endometriosis.